Cargando…

Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers

Accurate prediction of clinical changes of mild cognitive impairment (MCI) patients, including both qualitative change (i.e., conversion to Alzheimer's disease (AD)) and quantitative change (i.e., cognitive scores) at future time points, is important for early diagnosis of AD and for monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Daoqiang, Shen, Dinggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310854/ https://www.ncbi.nlm.nih.gov/pubmed/22457741 http://dx.doi.org/10.1371/journal.pone.0033182

Ejemplares similares

Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features
por: Minhas, Sidra, et al.
Publicado: (2021)

Hierarchical Anatomical Brain Networks for MCI Prediction: Revisiting Volumetric Measures
por: Zhou, Luping, et al.
Publicado: (2011)

Estimating sparse functional brain networks with spatial constraints for MCI identification
por: Xue, Yanfang, et al.
Publicado: (2020)

Predicting MCI Status From Multimodal Language Data Using Cascaded Classifiers
por: Fraser, Kathleen C., et al.
Publicado: (2019)

Correction: Estimating sparse functional brain networks with spatial constraints for MCI identification
por: Xue, Yanfang, et al.
Publicado: (2021)

Multi-Task Linear Programming Discriminant Analysis for the Identification of Progressive MCI Individuals
por: Yu, Guan, et al.
Publicado: (2014)

Improving Sparsity and Modularity of High-Order Functional Connectivity Networks for MCI and ASD Identification
por: Zhou, Yueying, et al.
Publicado: (2018)

Estimating Brain Functional Networks Based on Adaptively-Weighted fMRI Signals for MCI Identification
por: Chen, Huihui, et al.
Publicado: (2021)

A Machine Learning Classifier for Predicting Stable MCI Patients Using Gene Biomarkers
por: Lin, Run-Hsin, et al.
Publicado: (2022)

Resting-State Multi-Spectrum Functional Connectivity Networks for Identification of MCI Patients
por: Wee, Chong-Yaw, et al.
Publicado: (2012)

QEEG- BRAIN MAPPING - A biomarker to predict MCI/ Dementia.
por: Murugappan, SP., et al.
Publicado: (2022)

Classifying MCI Subtypes in Community-Dwelling Elderly Using Cross-Sectional and Longitudinal MRI-Based Biomarkers
por: Guan, Hao, et al.
Publicado: (2017)

Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study
por: Teng, Lirong, et al.
Publicado: (2020)

Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry
por: Long, Xiaojing, et al.
Publicado: (2018)

Biomarker testing in MCI patients—deciding who to test
por: van Maurik, Ingrid S., et al.
Publicado: (2021)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Multimodal multitask learning for predicting MCI to AD conversion using stacked polynomial attention network and adaptive exponential decay
por: Ho, Ngoc-Huynh, et al.
Publicado: (2023)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Comparing model‐based cerebrovascular physiomarkers with DTI biomarkers in MCI patients
por: Marmarelis, Vasilis Z., et al.
Publicado: (2019)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

Optimising and Future-Proofing Dementia Care With Amnestic Mild Cognitive Impairment (aMCI) Clinics
por: Raninga, Smit Kishorbhai, et al.
Publicado: (2023)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Searching for optimal machine learning model to classify mild cognitive impairment (MCI) subtypes using multimodal MRI data
por: Jitsuishi, Tatsuya, et al.
Publicado: (2022)

A Longitudinal Study of Episodic and Semantic Autobiographical Memory in aMCI and Alzheimer’s Disease Patients
por: Meléndez, Juan C., et al.
Publicado: (2021)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator
por: Pang, Y., et al.
Publicado: (2023)

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
por: Luis, Cheryl A., et al.
Publicado: (2011)

Motor and Sensory Function as Predictors of MCI and Dementia in the Baltimore Longitudinal Study of Aging (BLSA)
por: Schrack, Jennifer, et al.
Publicado: (2021)

Multimodal Brain Network Jointly Construction and Fusion for Diagnosis of Epilepsy
por: Zhu, Qi, et al.
Publicado: (2021)

Frontotemporal EEG as potential biomarker for early MCI: a case–control study
por: Mitsukura, Yasue, et al.
Publicado: (2022)

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
por: Caminiti, Silvia Paola, et al.
Publicado: (2018)

Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes
por: Beversdorf, Lucas J., et al.
Publicado: (2015)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets
por: Berres, Manfred, et al.
Publicado: (2021)

White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2021)

GACDN: generative adversarial feature completion and diagnosis network for COVID-19
por: Zhu, Qi, et al.
Publicado: (2021)

EpiMCI: Predicting Multi-Way Chromatin Interactions from Epigenomic Signals
por: Xu, Jinsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59l0n4l167hs7iobm7529p53va